Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T16:57:29.764Z.
Calculation as of: 2026-10-06T16:57:29.764Z.
Quote observation: 2026-10-06T16:55:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 75157c8a62e3fe86a7e5d9b3960d4dd2a79ae28b02be5cac6a633fb547f90e56
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Jyong Biotech Ltd. Ordinary Shares
Market Cap
$155.86M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$158.40M
Free Cash Flow Yield
N/A
TTM Avg
1.28%
3Y Avg
1.28%
5Y Avg
1.28%
Market Cap
$152.06M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$151.58M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$161.45M
Free Cash Flow Yield
N/A
TTM Avg
0.52%
3Y Avg
0.52%
5Y Avg
7.43%
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jyong Biotech Ltd. Ordinary Shares (MENS) | $155.86M | N/A | N/A | N/A | N/A |
| Neuronetics, Inc. (STIM)vs › | $156.07M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $157.03M | N/A | 1.49% | 2.55% | 2.12% |
| Minerva Neurosciences, Inc. (NERV)vs › | $158.40M | N/A | 1.28% | 1.28% | 1.28% |
| ALX Oncology Holdings Inc. (ALXO)vs › | $152.06M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $151.58M | N/A | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $150.95M | N/A | 2.70% | 2.70% | 2.70% |
| Coherus Oncology, Inc. (CHRS)vs › | $161.45M | N/A | 0.52% | 0.52% | 7.43% |
| PepGen Inc. (PEPG)vs › | $161.51M | N/A | N/A | N/A | N/A |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $149.18M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
